Published in Harv Rev Psychiatry on August 30, 2002
Feeling and time: the phenomenology of mood disorders, depressive realism, and existential psychotherapy. Schizophr Bull (2006) 1.18
Multi-scale motility amplitude associated with suicidal thoughts in major depression. PLoS One (2012) 0.87
Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. J Affect Disord (2010) 0.82
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One (2012) 0.79
How many bipolar mixed states are there? Harv Rev Psychiatry (2002) 0.78
The State of the Art of the DSM-5 "with Mixed Features" Specifier. ScientificWorldJournal (2015) 0.76
Historical overview: Kraepelin's impact on psychiatry. Eur Arch Psychiatry Clin Neurosci (2008) 0.75
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40
International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 3.14
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00
Transanal minimally invasive surgery: a giant leap forward. Surg Endosc (2010) 2.93
Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry (2008) 2.44
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Modern antipsychotic drugs: a critical overview. CMAJ (2005) 1.98
EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry (2002) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry (2003) 1.84
Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77
Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med (2006) 1.68
Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. J Infect Dis (2005) 1.64
Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry (2002) 1.62
Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49
Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry (2002) 1.49
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom (2013) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42
Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord (2010) 1.41
Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord (2008) 1.35
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28
Suicide risk and treatments for patients with bipolar disorder. JAMA (2003) 1.26
Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry (2006) 1.24
Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry (2006) 1.22
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord (2006) 1.18
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology (2011) 1.18
Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry (2007) 1.17
Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry (2011) 1.14
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology (2008) 1.14
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13
Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum (2010) 1.13
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2007) 1.12
Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord (2004) 1.11
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11
Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol (2013) 1.10
Advances in development of dopaminergic aporphinoids. J Med Chem (2007) 1.10
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry (2005) 1.06
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol (2003) 1.06
Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04
Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev (2013) 1.03
Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry (2007) 0.99
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc (2009) 0.98
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl) (2002) 0.98
Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry (2003) 0.97
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther (2002) 0.97
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord (2005) 0.97
Facial reactions in response to dynamic emotional stimuli in different modalities in patients suffering from schizophrenia: a behavioral and EMG study. Front Hum Neurosci (2013) 0.97
Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord (2013) 0.96
Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary. Harv Rev Psychiatry (2009) 0.96
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (2006) 0.95
Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord (2010) 0.94
Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol (2011) 0.93
Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology (2004) 0.93
Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2013) 0.92
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92
Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol (2005) 0.92
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord (2008) 0.92
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci (2004) 0.92
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord (2007) 0.91
Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol (2006) 0.91
Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord (2004) 0.91
Suicidal risk factors in bipolar I and II disorder patients. J Clin Psychiatry (2011) 0.91
Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res (2004) 0.91
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother (2005) 0.91
Scaling behavior of human locomotor activity amplitude: association with bipolar disorder. PLoS One (2011) 0.91
Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord (2008) 0.90
Pretreatment episode count and response to lithium treatment in manic-depressive illness. Harv Rev Psychiatry (2003) 0.90
Effects of risperidone on dopamine receptor subtypes in developing rat brain. Eur Neuropsychopharmacol (2006) 0.90
Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl) (2001) 0.90
Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview. Depress Anxiety (2014) 0.89
Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review. CNS Drugs (2009) 0.88
Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. Handb Clin Neurol (2011) 0.88
Cycloid psychoses revisited: case reports, literature review, and commentary. Harv Rev Psychiatry (2008) 0.88
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. CNS Drugs (2002) 0.88